Study suggests that surgical resection or multimodal therapy, including surgery, significantly improves overall survival in selected patients with metastatic oesophageal cancer compared to chemotherapy alone. Resection as an independent factor for favourable survival was confirmed, highlighting its feasibility as a treatment option. Prospective randomized studies are needed to validate these findings and establish reliable selection criteria for optimal patient outcomes.
Journal Article by Knipper K, Lemties J (…) Schmidt T et 11 al. in BJS Open
© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.
